(Q36994648)

17 August 2017

1 reference

title

Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations (English)

1 reference

17 August 2017

1 reference

1 reference

1 reference

Linda Cox

1

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Current Allergy and Asthma Reports

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

410-420

1 reference

https://scigraph.springernature.com/pub.10.1007/s11882-007-0063-6

17 August 2017

exact match

0 references

cites work

Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma

1 reference

12 December 2020

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

1 reference

12 December 2020

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

1 reference

12 December 2020

Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy

1 reference

12 December 2020

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

1 reference

12 December 2020

Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study

1 reference

12 December 2020

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study

1 reference

12 December 2020

Sublingual immunotherapy: a comprehensive review.

1 reference

12 December 2020

Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study

1 reference

12 December 2020

Dose dependence of immunological response to sublingual immunotherapy

1 reference

12 December 2020

Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study

1 reference

12 December 2020

Psychological stress affects response to sublingual immunotherapy in asthmatic children allergic to house dust mite.

1 reference

12 December 2020

Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children

1 reference

12 December 2020

Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis

1 reference

12 December 2020

Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan

1 reference

12 December 2020

Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients

1 reference

12 December 2020

Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

1 reference

12 December 2020

Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy

1 reference

12 December 2020

Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children

1 reference

12 December 2020

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

1 reference

12 December 2020

Allergen immunotherapy: a practice parameter second update

1 reference

12 December 2020

Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen.

1 reference

12 December 2020

Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project: Evaluation of A novel SLIT formulation during a Year)

1 reference

12 December 2020

Anaphylaxis to multiple pollen allergen sublingual immunotherapy

1 reference

12 December 2020

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

12 December 2020

Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.

1 reference

12 December 2020

Quantitative assessment of the adherence to sublingual immunotherapy

1 reference

12 December 2020

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

1 reference

12 December 2020

Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.

1 reference

12 December 2020

Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma

1 reference

12 December 2020

Anaphylaxis by latex sublingual immunotherapy

1 reference

12 December 2020

A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects

1 reference

12 December 2020

Long-term clinical efficacy of grass-pollen immunotherapy

1 reference

12 December 2020

Immunomodulation during sublingual therapy in allergic children

1 reference

12 December 2020

Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs

1 reference

12 December 2020

Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization

1 reference

12 December 2020

Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study

1 reference

12 December 2020

Long-term effects of budesonide or nedocromil in children with asthma.

1 reference

12 December 2020

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

1 reference

12 December 2020

Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study.

1 reference

12 December 2020

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

1 reference

12 December 2020

Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis

1 reference

12 December 2020

Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study

1 reference

12 December 2020

Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract

1 reference

12 December 2020

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

1 reference

12 December 2020

Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care

1 reference

12 December 2020

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

1 reference

12 December 2020

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children

1 reference

12 December 2020

Natural history of hay fever: a 23-year follow-up of college students

1 reference

12 December 2020

Pharmacoeconomic considerations for allergen immunotherapy.

1 reference

12 December 2020

Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial

1 reference

12 December 2020

Long-term inhaled corticosteroids in preschool children at high risk for asthma

1 reference

12 December 2020

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

1 reference

12 December 2020

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

12 December 2020

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid

1 reference

12 December 2020

Systemic reactions from allergen immunotherapy

1 reference

12 December 2020

Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study

1 reference

12 December 2020

Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.

1 reference

12 December 2020

Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood

1 reference

12 December 2020

Safety of sublingual immunotherapy with a monomeric allergoid in very young children.

1 reference

12 December 2020

Children's compliance with allergen immunotherapy according to administration routes

1 reference

12 December 2020

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

1 reference

12 December 2020

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

1 reference

12 December 2020

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy

1 reference

12 December 2020

Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract

1 reference

12 December 2020

Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.

1 reference

12 December 2020

Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial

1 reference

12 December 2020

Immunologic response to administration of standardized dog allergen extract at differing doses.

1 reference

12 December 2020

10.1007/S11882-007-0063-6

Identifiers

DOI

1 reference

17 August 2017

1 reference